Jung Carolin, Gillmann Hans-Jörg, Stueber Thomas
Department of Anaesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany.
Department of Anaesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany.
J Cardiothorac Vasc Anesth. 2024 Jan;38(1):221-229. doi: 10.1053/j.jvca.2023.09.040. Epub 2023 Oct 1.
Patients with severe acute respiratory distress syndrome (ARDS) often exhibit an unusually strong respiratory drive, which predisposes them to effort-induced lung injury. Careful titration of support pressure via the ventilator and carbon dioxide removal via extracorporeal membrane oxygenation (ECMO) may attenuate respiratory drive and lung stress.
A retrospective cohort study.
At a single center, a university hospital.
Ten patients with severe COVID-19-associated ARDS (CARDS) on venovenous ECMO therapy.
Assessment of the effect of titrated support pressure and titrated ECMO sweep gas flow on respiratory drive and lung stress in spontaneously breathing patients during ECMO therapy.
Airway occlusion pressure (P) and the total swing of the transpulmonary pressure were determined as surrogate parameters of respiratory drive and lung stress. Ventilator-mediated elevation of support pressure decreased P but increased transpulmonary driving pressure, airway pressure, tidal volume, and end-inspiratory transpulmonary occlusion pressure. The increase in ECMO sweep gas flow lowered P, transpulmonary pressures, tidal volume, and respiratory frequency linearly.
In patients with CARDS on pressure support ventilation, even moderate support pressure may lead to overassistance during assisted ventilation, which is only reflected by advanced monitoring of respiratory mechanics. Modifying carbon dioxide removal via the extracorporeal system profoundly affects respiratory effort and mechanics. Spontaneously breathing patients with CARDS may benefit from consequent carbon dioxide removal.
重症急性呼吸窘迫综合征(ARDS)患者常表现出异常强烈的呼吸驱动力,这使他们易发生用力性肺损伤。通过呼吸机仔细滴定支持压力以及通过体外膜肺氧合(ECMO)去除二氧化碳可能会减弱呼吸驱动力和肺应激。
一项回顾性队列研究。
在一家大学医院的单一中心。
10例接受静脉-静脉ECMO治疗的重症新型冠状病毒肺炎相关ARDS(CARDS)患者。
评估滴定的支持压力和滴定的ECMO扫气流量对ECMO治疗期间自主呼吸患者的呼吸驱动力和肺应激的影响。
气道闭塞压(P)和跨肺压的总波动被确定为呼吸驱动力和肺应激的替代参数。呼吸机介导的支持压力升高会降低P,但会增加跨肺驱动压、气道压力、潮气量和吸气末跨肺闭塞压。ECMO扫气流量的增加会使P、跨肺压、潮气量和呼吸频率呈线性降低。
在接受压力支持通气的CARDS患者中,即使是适度的支持压力也可能导致辅助通气期间的过度辅助,这仅通过对呼吸力学的高级监测来体现。通过体外系统改变二氧化碳清除对呼吸用力和力学有深远影响。自主呼吸的CARDS患者可能会从相应的二氧化碳清除中获益。